How I treat incidental pulmonary embolism

Blood

Volumn 125, Issue 12, 2015, Pages 1877-1882

  O'Connell, Casey ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; DABIGATRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUING EDUCATION; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; INCIDENTAL FINDING; KIDNEY CARCINOMA; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHRECTOMY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY; SYMPTOMATIC SUBSEGMENTAL PULMONARY EMBOLISM; TREATMENT DURATION; TREATMENT INDICATION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; COLORECTAL TUMOR; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; HEMATOLOGY; PROCEDURES; PULMONARY EMBOLISM; RADIOGRAPHY; RISK FACTOR;

AGED; CARCINOMA, RENAL CELL; COLORECTAL NEOPLASMS; FEMALE; HEMATOLOGY; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925372716     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-551879     Document Type: Article

References (33)

1. O'Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol. 2006;24(30):4928-4932.
2. Khorana AA, O'Connell C, Agnelli G, Liebman HA, Lee AY; Subcommittee on Hemostasis and Malignancy of the SSC of the ISTH. Incidental venous thromboembolism in oncology patients. J Thromb Haemost. 2012;10(12):2602-2604.
3. Kalra MK, Maher MM, D'Souza R, Saini S. Multidetector computed tomography technology: current status and emerging developments. J Comput Assist Tomogr. 2004;28(suppl 1):S2-S6.
4. Napoli A, Fleischmann D, Chan FP, et al. Computed tomography angiography: state-of-the-art imaging using multidetector-row technology. J Comput Assist Tomogr. 2004;28(suppl 1):S32-S45.
5. Patel S, Kazerooni EA, Cascade PN. Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT. Radiology. 2003;227(2):455-460.
6. Farrell C, Jones M, Girvin F, Ritchie G, Murchison JT. Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients. Clin Radiol. 2010;65(1):1-5.
7. Pena E, Kimpton M, Dennie C, Peterson R, LE Gal G, Carrier M. Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism. J Thromb Haemost. 2012;10(3):496-498.
8. Aviram G, Levy G, Fishman JE, Blank A, Graif M. Pitfalls in the diagnosis of acute pulmonary embolism on spiral computer tomography. Curr Probl Diagn Radiol. 2004;33(2):74-84.
9. Wells PS, Ginsberg JS, Anderson DR, et al. Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism. J Intern Med. 2001;250(3):262-264.
10. Stein PD, Goodman LR, Hull RD, Dalen JE, Matta F. Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost. 2012;18(1):20-26.
11. Jiménez D, Aujesky D, Díaz G, et al RIETE Investigators. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med. 2010;181(9):983-991.
12. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res. 2010;125(6):518-522.
13. O'Connell CL, Razavi PA, Liebman HA. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol. 2011;29(31):4208-4209, author reply 4209-4210.
14. Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med. 1994;235(5):457-461.
15. th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2, suppl):e419S-e494S.
16. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960;1(7138):1309-1312.
17. Gandhi R, Salonen D, Geerts WH, Khanna M, McSweeney S, Mahomed NN. A pilot study of computed tomography-detected asymptomatic pulmonary filling defects after hip and knee arthroplasties. J Arthroplasty. 2012;27(5):730-735.
18. Agnelli G, Buller HR, Cohen A, et al PLIFY-EXT Investigators. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368(8):699-708.
19. Dentali F, Ageno W, Pierfranceschi MG, et al. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost. 2011;9(5):1081-1083.
20. den Exter PL, Hooijer J, Dekkers OM, Huisman MV. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol. 2011;29(17):2405-2409.
21. O'Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost. 2011;9(2):305-311.
22. Lyman GH, Khorana AA, Kuderer NM, et al American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(17):2189-2204.
23. Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer. 2010;69(3):330-336.
24. Vedovati MC, Germini F, Agnelli G, Becattini C. Direct oral anticoagulants in patients with venous thromboembolism and cancer: a systematic review and meta-analysis [published online ahead of print September 11, 2014]. Chest. 2014. doi:10.1378/chest.14-0402.
25. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010;8(8):1716-1722.
26. Donato AA, Khoche S, Santora J, Wagner B. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res. 2010;126(4):e266-e270.
27. den Exter PL, van Es J, Klok FA, et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood. 2013;122(7):1144-1149, quiz 1329.
28. van der Hulle T, den Exter PL, Meyer G, et al. Risk of recurrent venous thromboembolism and major bleeding in cancer-associated incidental pulmonary embolism amongst treated and untreated patients: a pooled analysis of 926 patients [abstract]. Blood. 2014;124(21). Abstract 590.
29. Yoo HH, Queluz TH, El Dib R. Anticoagulant treatment for subsegmental pulmonary embolism. Cochrane Database Syst Rev. 2014;4:CD010222.
30. Sijens PE, van Ingen HE, van Beek EJR, Berghout A, Oudkerk M. Rapid ELISA assay for plasma D-dimer in the diagnosis of segmental and subsegmental pulmonary embolism. A comparison with pulmonary angiography. Thromb Haemost. 2000;84(2):156-159.
31. Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846-1850.
32. Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies. Thromb Haemost. 2013;110(2):205-212.
33. Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 2013;122(24):3879-3883.